Blog: News
Explore PYFA’s end-to-end CDMO solutions, from product development and formulation to manufacturing, regulatory support, and market access—helping pharmaceutical partners bring innovative products to market efficiently across Indonesia and Asia-Pacific.
Pyridam Farma (PYFA) Records Significant Growth, Revenue Doubles with a Target of Rp 3 Trillion Next Year
PT Pyridam Farma Tbk (PYFA) and RGCC Forge Strategic Partnership, Bringing Cancer Treatment Innovation to Indonesia
PYFAGROUP’s Commitment to the Nation’s Health is Realized Through the Expansion of Ethica Industri Farmasi’s Injection Production Facility
PYFAGROUP Becomes the First to Launch CDMO Services in the Global Pharmaceutical Industry
Pyridam Farma Acquires Major Australian Pharmaceutical Company, Expands into Global Market.
PYFAESTHETIC Successfully Holds Soft Launching of Carboxy Therapy in Jakarta and Surabaya
